Analysed IDORSIA LTD (IDRSF:OTCMKTS) News Sources
Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon
09-06-2026
yahoo.com
Insomnia Market Witnesses Robust Growth During the Forecast Period (2026-2036) with Emerging Orexin Receptor Antagonists and Melatonin Receptor Agonist | DelveInsight
18-06-2026
yahoo.com
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
26-06-2026
yahoo.com
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
23-07-2026
yahoo.com
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
27-07-2026
yahoo.com
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
30-07-2026
yahoo.com
What is the current price of IDORSIA LTD (IDRSF:OTCMKTS)?
The current price of IDORSIA LTD (IDRSF:OTCMKTS) is $8.
IDORSIA LTD (IDRSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of IDORSIA LTD (IDRSF:OTCMKTS) since the previous trading day is $-0.19.
IDORSIA LTD (IDRSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of IDORSIA LTD (IDRSF:OTCMKTS) since the previous trading day is -2.3199%.
What is the most recent average sentiment score for IDORSIA LTD (IDRSF:OTCMKTS)?
The most recent average sentiment score for IDORSIA LTD (IDRSF:OTCMKTS) is 67 out of 100.
What is the most recent average sentiment for IDORSIA LTD (IDRSF:OTCMKTS)?
The most recent sentiment for IDORSIA LTD (IDRSF:OTCMKTS) is .
SEC-8K** Filing Available For IDORSIA LTD (IDRSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.